Alcohol Dependence Clinical Trial
Official title:
Cerebral Hemodynamics With rTMS in Alcohol Dependence: A Randomized, Sham Controlled Study
The present study measures the cerebral hemodynamic indices of alcohol dependent patients and observe the relative changes in these parameters with rTMS application.
Alcohol abuse is a worldwide problem causing serious physical, psychological, social and
economic consequences. Chronic alcohol intake has been found to increased blood viscosity,
erythrocyte deformability or dehydration resulting in alterations of cerebral blood flow
measures. Transcranial Doppler (TCD) sonography is a non-invasive radiological tool used for
assessing the hemodynamics of the basal cerebral arteries, which can thus indirectly reflect
the relative changes in regional cerebral blood flow velocity (CBFV) and vascular wall
resistance. It has been used to evaluate the relative cerebral blood flow velocity changes
in various psychiatric disorders like depression, schizophrenia, panic disorder, and
substance use disorders including alcohol and marijuana. TCD also gives a real time
assessment of the abrupt or short and long lasting effects of any external mechanical
manipulation or functional stimulation of the intracranial circulation.
The Mean flow velocity (MV) is the average of the edge frequency over a cardiac cycle; the
edge frequency being the envelope of instantaneous peak velocities throughout the course of
a cardiac cycle. Pulsatility index (PI) represents an estimate of downstream vascular
resistance; low resistance vascular beds have higher diastolic flow velocities than high
resistance vascular beds, hence they have low PI, and vice versa. Similarly, Resistance
index (RI) is another presumptive measure of downstream vascular resistance.
TCD sonography studies in alcoholism have revealed reduced mean blood flow velocities in
basal cerebral arteries in chronic alcohol dependence, [1] as well as in acute stage of
intoxication, but an increase after resolution of withdrawal state. [12] However, ethanol in
low concentration has been found to increase the systolic, diastolic and mean blood flow
velocity in middle cerebral arteries (MCA), anterior cerebral arteries (ACA) and decrease
the resistance indices by reducing the cerebrovascular resistance in healthy individuals.
Studies have reported that alcohol related hepatic dysfunction results in increased blood
viscosity and reduced velocity in the cerebral arteries, which can be a risk factor for
ischemic brain diseases. So, normalization of hemodynamic parameters is important in the
prevention of possible ischemic brain diseases due to alcohol dependence.
Studies evaluating cerebral hemodynamic response to rTMS application have been limited to
healthy individuals, with high frequency rTMS application found to increase the cerebral
blood flow velocities in both anterior and posterior basal cerebral arteries, and low
frequency rTMS to temporarily decrease the blood flow velocity in ipsilateral MCA followed
by an increase in the contralateral MCA. With this background, the present study was
conducted to measure the cerebral hemodynamic indices of alcohol dependent patients and
observe the relative changes in these parameters with rTMS application.
;
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02901041 -
Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism
|
Phase 3 | |
Completed |
NCT03340051 -
Remote Alcohol Monitoring and Episodic Thinking
|
N/A | |
Not yet recruiting |
NCT06444243 -
Psilocybin-assisted Therapy for Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02486900 -
Neurofeedback & Alcohol Dependence
|
N/A | |
Completed |
NCT02705898 -
Lifestyle Physical Activity Intervention for Depressed Alcohol Dependent Women
|
N/A | |
Completed |
NCT02197598 -
Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use
|
Phase 4 | |
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Recruiting |
NCT02385643 -
The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients
|
N/A | |
Completed |
NCT01828866 -
Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients
|
N/A | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Active, not recruiting |
NCT01182766 -
New Treatment for Alcohol and Nicotine Dependence
|
Phase 2/Phase 3 | |
Completed |
NCT01342549 -
Treatment Strategy for Alcohol Use Disorders in Veterans With TBI
|
Phase 3 | |
Completed |
NCT02193204 -
Chronic Alcohol, Stress Inflammatory Response and Relapse Risk
|
N/A | |
Completed |
NCT01176591 -
HBPL Study of the Impact of the NK1 Antagonist Aprepitant
|
Phase 2 | |
Completed |
NCT01165541 -
A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency
|
Phase 2 | |
Completed |
NCT00585780 -
Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse
|
Phase 1/Phase 2 | |
Completed |
NCT01056484 -
Mindfulness Meditation for Health
|
Phase 2 | |
Completed |
NCT00607620 -
Disseminating Organizational SBI Services at Trauma Centers
|
N/A | |
Completed |
NCT00884884 -
Aripiprazole and Topiramate on Free-Choice Alcohol Use
|
Phase 2/Phase 3 | |
Completed |
NCT00463346 -
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
|
Phase 3 |